Federal
Register Notices > Notices
of Application - 2005 >
Research Triangle Institute
FR Doc 05-16467 [Federal Register: August 19, 2005 (Volume 70, Number
160)] [Notices] [Page 48779-48780] From the Federal Register Online via
GPO Access [wais.access.gpo.gov] [DOCID:fr19au05-77]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21
U.S.C. 958(i), the Attorney General shall, prior to issuing a
registration under this section to a bulk manufacturer of a controlled
substance in Schedule I or II and prior to issuing a regulation under 21
U.S.C. 952(a)(2)(B) authorizing the importation of such a substance,
provide
[[Page 48780]]
manufacturers holding registrations for the bulk manufacture of the
substance an opportunity for a hearing.
Therefore, in accordance with 21 CFR 1301.34(a), this is notice that
on April 8, 2005, Research Triangle Institute, Kenneth H. Davis Jr.,
Hermann Building East Institute Drive, P.O. Box 12194, Research Triangle
Park, North Carolina 27709, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as an importer of the
basic class of controlled substance listed in Schedule II:
Drug
|
Schedule
|
Cocaine (9041)
|
II
|
The company plans to import small quantities of the listed controlled
substance for the National Institute of Drug Abuse and other clients.
Any manufacturer who is presently, or is applying to be, registered
with DEA to manufacture such basic classes of controlled substances may
file comments or objections to the issuance of the proposed registration
and may, at the same time, file a written request for a hearing on such
application pursuant to 21
CFR 1301.43 and in such form as prescribed by 21
CFR 1316.47.
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria,
Virginia 22301; and must be filed no later than September 19, 2005.
This procedure is to be conducted simultaneously with and independent
of the procedures described in 21 CFR 1301.34(b), (c), (d), (e) and (f).
As noted in a previous notice published in the Federal Register on
September 23, 1975, (40 FR 43745-46), all applicants for registration to
import a basic class of any controlled substance listed in Schedule I or
II are, and will continue to be required to demonstrate to the Deputy
Assistant Administrator, Office of Diversion Control, Drug Enforcement
Administration, that the requirements for such registration pursuant to
21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1301.34(b), (c),(d),(e)
and (f) are satisfied.
Dated: August 11, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-16467 Filed 8-18-05; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|